Clinical Trials Directory

Trials / Completed

CompletedNCT00378625

Efficacy, Effect on Gametocytes and Tolerability of the Addition of Artesunate to Amodiaquine in Colombia

Randomised, Double Blind Clinical Trial of the Efficacy, Effect on Gametocytes and Tolerability of Amodiaquine Vs Amodiaquine Plus Artesunate in the Treatment of Uncomplicated P. Falciparum Malaria in Quibdo, Colombia

Status
Completed
Phase
Phase 3
Study type
Interventional
Enrollment
360 (planned)
Sponsor
Centro Internacional de Entrenamiento e Investigaciones Médicas · Academic / Other
Sex
All
Age
1 Year – 65 Years
Healthy volunteers
Not accepted

Summary

The primary goal of this study is to quantify the benefit of adding artesunate to amodiaquine in treating patients with uncomplicated P. falciparum malaria, in a low transmission area in Colombia. The benefit will be assessed in terms of: * Efficacy * Tolerability * Time of fever clearance * Time of parasite clearance * Proportion of gametocyte carriers

Conditions

Interventions

TypeNameDescription
DRUGArtesunate

Timeline

Start date
2000-04-01
Completion
2006-03-01
First posted
2006-09-20
Last updated
2006-09-20

Locations

1 site across 1 country: Colombia

Source: ClinicalTrials.gov record NCT00378625. Inclusion in this directory is not an endorsement.